Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Atenolol on Post-Operative Cytokines
NCT00202358Phase 4Unknown
- Sponsor
- Saini Foundation
- Start
- Nov 2002
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in operative procedure comparing placebo with atenolol (2 arms). Primary endpoints: Interleukin-6 levels at 6 weeks and C-Reactive Protein levels at 6 weeks. Status: unknown.
02
Drugs
atenolol
03
Conditions
operative procedure
Beyond the preview
Go deeper on NCT00202358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00202358.